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Abstract Sialic acid (SA) is normally expressed on the cell
membranes and is located at the terminal position of the sugar
chains. SA plays an important role for regulation of the innate
immunity, function as markers of the cells and can be recog-
nized by a variety of receptors. Interestingly, the level of SA
expression is increased on metastatic cancer cells. The avail-
ability of specific antibodies against SA is limited and, there-
fore, biomarker tools for detection of SA are lacking. We have
recently presented a novel method for specific fluorescence
labeling of SAmolecular imprinted polymers (MIP). Here, we
have performed an extended screening of SA expression by
using SA-MIP and included four different chronic lymphocyt-
ic leukemia (CLL) cell lines, conveniently analyzed by flow
cytometry and fluorescence microscopy. SA expression was
detected in four cell lines at different levels, and the SA ex-
pression were verified with lectin-FITC. These results show
that SA-MIP can be used as a plastic antibody for detection of
SA using both flow cytometry and fluorescence microscopy.
We suggest that SA-MIP can be used for screening of different
tumor cells of various stages, including CLL cells.
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Introduction
Glycans, or polysaccharides, are present on the outer surface
of most eukaryotic cells and are involved in various cell pro-
cesses, including protecting the cells from intruders and in
cellular connection. Attachment of O- and N-linked glycans
to proteins for the generation of glycoproteins is very common
structural motifs [1]. Sialic acid (SA) plays an important role
for regulation of the innate immunity and may have an inhib-
itory effect on complement activation [2]. SA’s attached at the
end of glycan chains provides a negative charge on the cell
surface, which is required for trafficking of cells. SA functions
as a cellular marker and can be recognized by a variety of
receptors [3]. In the late 80s, an association between SA and
cancer was discovered, especially on metastatic cancer [4, 5].
Fuster reported that overexpression of SA in metastatic cancer
controls tumor cell growth and differentiation by interfering
with neural cell adhesion molecule signaling at cell-cell con-
tacts [1, 6]. Overexpression of tumor-associated SA in meta-
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whether there is a benefit of the combination of anti-SA im-
munotherapy and anti-proliferative drugs [7].
Analyzing and determining these glycosylation motifs is
therefore an important diagnostic goal but the task is a chal-
lenge due to the limited availability of appropriate lectins and
glycan-specific antibodies [8, 9]. This calls for the develop-
ment of alternative glycan-specific probes and cell imaging
technologies. Recent reports have shown that synthetic probes
based on host guest chemistry [10] or molecular imprinting
technology [11] can be used for glycan selective staining of
cells and tissues. Using the former approach, Xu and col-
leagues developed fluorescent sensors based on two boronic
acids linked to a functionalized peptide for detection of cell-
surface cancer-associated glycans [10]. On the other hand,
imaging probes based on phenylboronic acid-modified quan-
tum dots have also been used, allowing specific labeling of SA
on living cells [12]. However, this approach has the weakness
of targeting diols in a non-specific manner.
Molecular imprinting, as a design concept, is in this context
more attractive. Artificial receptors are produced by allowing a
network polymer to assemble in the presence of a template.
After removing the template, the resultingmolecularly imprinted
polymer (MIP) can be used as an artificial antibody [13]. A key
advantage of this technique is that it can be used for recognizing
less immunogenic targets such as glycans [14]. Moreover, com-
pared with antibodies, MIPs can be produced at low cost and
feature superior robustness and long-term stability [15].
Recently, different monosaccharide imprinting procedures
were used to produce fluorescently labeled nanoparticle
probes displaying an unprecedented affinity for the targeted
terminal monosaccharides in cell staining experiments [16].
Based on a ternary complex imprinting approach, we devel-
oped imprinted core-shell nanoparticles showing an exception-
al affinity for cell surface SA-glycans. The probe comprised a
nitrobenzoxadiazole (NBD) fluorescent reporter group show-
ing enhanced emission intensity in presence of the SA-guest. In
flow cytometry and fluorescence microscopy investigations,
the SA-MIP selectively targeted two different prostate cancer
cell lines DU145 and PC3, as well as the T leukemia cell line
Jurkat. The SA expression was verified with lectin-FITC [11].
In this study, we have performed an extended screening of SA
expression by using SA-MIP using four different chronic lym-
phocytic leukemia (CLL) cell lines, conveniently analyzed by
flow cytometry and fluorescence microscopy. Indeed, SA ex-
pression was detected in all four cell lines and at different levels.
Material and methods
Cell culture
Four CLL cell lines were used, HG3, CI, Wa-osel, and AIII
[17]. The cell lines were cultured in RPMI-1640 medium
(Invitrogen, San Diego, CA, USA) supplemented with 10 %
fetal bovine serum (FBS, Invitrogen) and 50 μg/mL
gentamycin (Invitrogen) and incubated in 37 °C with 5 %
CO2 in 100 % humidity.
Preparation of polymers
The polymers (SA-MIP) were prepared as described previous-
ly [11]. In brief, the dried SA-MIP were resuspended in water/
water and analyzed using (3 % methanol, Sigma-Aldrich Co.,
St. Louis, MI) and sonicated for 8 min with a VWR sonicator.
The stock solution of 0.8 mg/ml was further sonicated and
diluted prior to use.
Flow cytometry analysis of SA-MIP and lectin-FITC
1 × 106 cells/sample were stained with either SA-MIP, lectin-
FITC (Sigma-Aldrich) or left unstained as a control. The cells
of each CLL cell line were washed twice with 2 ml phosphate-
buffered saline (PBS, Invitrogen), and fixed with 1 ml of 4 %
formaldehyde (Sigma-Aldrich) and incubated for 20 min at
room temperature (RT). After fixation, the cells were washed
three times with 2 ml PBS and, thereafter, two times with 2 ml
3 % methanol. Five hundred microliters of a sonicated poly-
mer suspension of concentrations of 400, 200, 80, and
40 μg/ml, respectively, was added to the cells, and 500 μL
of 3 % methanol was used as a negative control. The cells
were incubated with SA-MIP for 90 min in 37 °C and were
thereafter washed three times with 2 ml 3 % methanol/water
and analyzed using flow cytometry (BD Biosciences, Accuri
C6 Flow Cytometry, NJ).
For lectin staining, cells were incubated with 500 μl of
lectin-FITC of concentrations 100, 50, 25, and 10 ng/ml or
left unstained as a negative control with 500 μl PBS. The cells
were incubated in the dark for 20 min, on ice, and were there-
after washed three times with 2 ml PBS and analyzed by flow
cytometry.
Ligand binding assay of SA based on flow cytometry
A ligand binding assay based on the flow cytometry anal-
ysis, i.e., quantification of cellular fluorescence of the
CLL cell lines was performed. The saturation capacity
of the binding sites in the SA-MIP was 10 μmol g−1
[11]. The binding curve was fitted by non-linear regres-
sion to a Langmuir mono-site model using the Prism 6
curve fitting software (Graph pad Inc.).
Fluorescence microscopy of SA-MIP and lectin-FITC
Fifty thousand cells/sample of HG3 cells were adhered to
poly-lysine treated slides (Thermo Scientific, MA) for 2 h, at
37 °C with 5 % CO2 in 100 % humidity. After the incubation,
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the cells were washed three times with PBS and fixed with
100 μl 4 % formaldehyde for 10 min. Thereafter, the cells
were washed three times with PBS and two times with 3 %
methanol, and the cells were incubated with 100 μl sonicated
SA-MIP at concentration of 100 μg/ml or left unstained with
100μl 3 %methanol at 37 °C for 60min. After the incubation,
the cells were washed four times with 3 % methanol and,
thereafter, twice with PBS, incubated with 300 nM DAPI in
PBS (Thermo Fisher Scientific, Carlsbad, CA), and incubated
for 4 min at RT. After three more washes with PBS, the cells
were mounted with one drop of mounting medium Prolong®
Gold antifade reagent (Molecular probes).
For lectin staining, HG3 cells were adhered to poly-
lysine-treated slides and, thereafter, fixed with 1 ml 4 %
formaldehyde, for 10 min at RT and, thereafter, washed
three times with PBS. The cells were incubated with
100 μl of lectin-FITC of concentration 100 ng/ml or left
unstained as a negative control with 100 μl PBS. The
cells were incubated with lectin-FITC at RT for 60 min.
Next, the cells were washed three times with PBS and
then incubated with 300 nM DAPI in PBS and incubated
for 4 min at RT. After three washes with PBS, the cells
were mounted with one drop of mounting medium
Prolong® Gold antifade reagent. The stained cells were
then analyzed using fluorescence microscopy (EVO® LS
10, Carl Zeiss, Jena, Germany).
Fig. 1 SA expression on the four CLL cell lines. Results of HG3, CI, Wa-
osel, and AIII cells stained with different concentrations of SA-MIP. Flow
cytometry results present a the positive cells for SA and b the MFI of the
SA binding. One representative experiment out of two performed is shown
Fig. 2 SA and lectin binding on HG3 cells. Flow cytometry analysis of
HG3 cells with different concentrations of SA-MIP (a) and lectin-FITC
(b). Black traces show the unstained samples, while the red traces show
SA-MIP (a) and lectin-FITC (B). The results are presented as MFI. One
representative experiment out of two performed is shown
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Results
Expression of SA in the four CLL cell lines HG3, CI,
Wa-osel, and AIII as detected by flow cytometry
The surface expression of SA in the four CLL cell lines was
investigated by flow cytometry. The fluorescence intensity of
the cell lines was different after staining with SA-MIP (200 and
400 μg/ml) (Fig. 1a). HG3 and CI showed a slightly higher
percentage of positive cells compared to the cell lines Wa-osel
and AIII. When comparing the mean fluorescence intensity
(MFI) among the four CLL cell lines, there were however no
major differences (Fig. 1b). Figure 2 displays the histogram for
the HG3 cell line with different concentrations of SA-MIP
(Fig. 2a) and lectin-FITC (Fig. 2b). An increase in binding for
SA-MIP to HG3 could be seen, but the lectin-FITC binding
was high even at lower concentrations of the lectin. However,
the lectin binding with the 10 ng/ml concentration varied
between the CLL cell lines (Fig. 3), being higher for HG3
and CI compared to the cell lines Wa-osel and AIII (Fig. 3a).
HG3 and CI showed highest specific binding in a ligand
binding assay
In a saturation ligand binding assay based on the flow cytom-
etry analysis, quantification of cellular fluorescence of the
CLL cell lines was possible by using one site specific binding
with Hill slope. The specific binding of SA was higher on
HG3 and CI compared to Wa-osel and AIII, (Fig. 4).
SA expression in the HG3 cell line as detected
by fluorescence microscopy
In order to visualize the glycans on the surface of the CLL cell
line HG3, the cells were stained with either SA-MIP (Fig. 5a),
lectin-FITC (Fig. 5b) or left unstained. All samples were
stained with DAPI for nuclear visualization and analyzed with
fluorescence microscopy. Overall, the SA-MIP led to a mem-
brane staining of the cells in a qualitatively similar way as
lectin-FITC. Staining with lectin-FITC led to a ring-shaped
fluorescence pattern all over the cell membrane.
Discussion
We have previously reported successful cell imaging experi-
ments, where SA-MIP particles selectively stained different cell
lines in correlation with the SA expression levels [11]. This was
further verified by enzymatic cleavage of SA and by staining
using a FITC-labeled lectin. SA plays an important role in a
variety of biological processes in cells. In this study, we were
primarily interested to verify any correlations with the aggres-
siveness of the CLL cell lines and SA expression levels [17].
Fig. 3 Lectin binding on the four CLL cell lines. Results of HG3, CI,
Wa-osel, and AIII cells stained with different concentrations of lectin-
FITC. Flow cytometry results present a the positive cells for lectin
binding and b the MFI of the lectin binding. One representative
experiment out of two performed is shown
Fig. 4 Quantification of cellular
fluorescence of the four CLL cell
lines. Specific ligand binding
assay based on flow cytometry for
the four CLL cell lines stained
with different concentrations of
SA-MIP. For each cell line, the
Kd (μM) and Bmax (% positive
cells) are shown
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SA expression is enhanced in metastatic cancer cells [18,
19]. CLL cells are CD5+/CD19+ B cells originating from
antigen-experiencedB1-like B-cells [20, 21]. Indeed, both nor-
mal and malignant leukocytes utilize adhesive interactions to
migrate throughout the body [22]. Selectins and the sialic-acid-
binding immunoglobulin-like lectins (Siglecs) are the intrinsic
receptors within vertebrate cells that recognize the SA.
Selectins have an important role in the spread of epithelial
cancers through the bloodstream. Studies in selectin-deficient
mice further confirmed a pivotal role of these glycan-binding
proteins in various models of cancer metastasis [23–25].
Siglec-2 (also known as CD22) is a member of the Siglec
family, expressed mostly on B cells, recognizes SA as a ligand
[26]. The four CLL cell lines used in this study, HG3, CI, Wa-
osel, and AIII, all expressed SA at different levels. For each
cell line, we show a dose-dependent increase in the number of
SA-positive cells as analyzed by flow cytometry. Interestingly,
two of the CLL cell lines, HG3 and CI, expressed higher levels
of SA compared to the other CLL cell lines, Wa-osel and AIII.
This is in line with the fact that the aggressiveness of the cancer
cells correlates with increasing SA levels [18, 19]. HG3 and CI
have an unmutated immunoglobulin heavy chain variable
(IGHV) gene, which is associated with high cell proliferation
and a more aggressive form of CLL compared with Wa-osel
and AIII cells, which have a mutated IGHV gene, a signature
of less aggressive indolent CLL cells [17].
Analyzing SA on leukocytes can be technically complex,
since SA has been shown to be masked by endogenous
sialylated ligands [27]. Sialidase treatment or cellular activa-
tion is necessary to unmask these sites, possibly by endoge-
nous sialidase efficiency. However, in this study, we could not
detect any differences in SA expression after anti-IgM ligation
for up to 72 h of the CLL cell lines (data not shown).
Many studies describe changes in glycosylation pattern
following neoplastic transformation. Defining the glycan ex-
pression of an individual epitope within tissue sections using
traditional approaches can be challenging [28, 29]. Improved
diagnostics and treatment of cancer is one of the most chal-
lenging tasks for researchers today. The transformation from a
normal cell into a tumor cell is a multistage process, typically a
progression from a pre-cancerous lesion to malignant tumors.
Despite the progress in developing new therapeutic modali-
ties, cancer remains one of the leading diseases causing hu-
man mortality [30]. Detection of SA has been limited due to
the lack of specific antibodies [9]. Here, we have used a highly
specific SA-MIP for detection of SA on CLL cell lines. We
suggest that SA-MIPs can be used for screening of different
circulating tumor cells of various stages, including CLL cells.
Further analysis of SA expression should include primary
CLL cells from patient samples.
Conclusions
We have demonstrated SA expression on CLL cell lines with
different levels of malignancy by using SA-MIPs. In conclu-
sion, SA-MIPs can be used as plastic antibodies for detection
of SA using both flow cytometry and fluorescence microsco-
py. SA-MIPs have high specificity and affinity for SA in dif-
ferent cell lines. In this context, we could detect differences of
SA expression in CLL cell lines.
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